Official reports from the 2014 cooperative meeting of CMSC & ACTRIMS – 5/30/2014

Biogen Idec

CMSC DAILY DIGEST: Official Reports from the 2014 Cooperative Meeting of CMSC and ACTRIMS

Friday, May 30, 2014

Photos of the day’s events included with each article!


*CMSC’s Nascent Longitudinal Database to Transform MS Care in Years Ahead* A CMSC-administered database now in its developmental stages will provide clinicians, patients, researchers, and drug developers with real-world, longitudinal data to guide their decision-making, thus transforming all aspects of multiple sclerosis (MS) care, Kottil Rammohan, MD, said in the keynote lecture that opened Thursday’s session of the 2014 Cooperative Meeting of CMSC and ACTRIMS in Dallas, TX… Read More	Kottil Rammohan, MD

*Complementary and Alternative Medicine in MS: Time to Move from Emotions to Evidence* Physicians and other health-care professionals need to move from “emotion-based medicine” to evidence-based medicine in assessing various complementary and alternative medicine (CAM) therapies for multiple sclerosis (MS) and in counseling patients regarding CAM… Read More	Allen C. Bowling, MD, PhD

*iTechnology in MS Patient Care and Research: Transformation – and Turbulence – Ahead* Healthcare providers and patients are experiencing the early stages of a technology revolution that will change all aspects of multiple sclerosis (MS) patient care and research, but – as with any revolution – there will be plenty of disruption, uncertainty, and false starts before the full benefits of technological advances are realized… Read More	Richard A. Rudick, MD

*MS in African-Americans: Time for Prospective, Multi-Center Studies to Explore Disease Biology, Other Factors* Despite varied types of data suggesting that multiple sclerosis (MS) in African Americans is marked by differences in disease biology from MS in Caucasians, gaping holes in our understanding of those perceived differences persist and can be filled only by prospectively designed, multi-center trials, Omar Khan, MD, told a symposium audience yesterday at the 2014 Cooperative Meeting of CMSC and ACTRIMS in Dallas, TX… Read More	Omar Khan, MD

*Progressive MS: A Pressing Need for Better Outcome Measures* There’s a lot of work that needs to be done to come up with better outcome measures in progressive multiple sclerosis, Megan Hyland, MD, MS, told symposium attendees yesterday at the 2014 Cooperative Meeting of CMSC and ACTRIMS in Dallas, TX… Read More	Megan Hyland, MD, MS

*Heterogeneity and Homogeneity in MS Lesions: Research Update* Recent research lends support to the hypothesis that multiple sclerosis (MS) is marked by intraindividual pathological homogeneity and interindividual heterogeneity, Imke Metz, MD, told a symposium audience yesterday at the 2014 Cooperative Meeting of CMSC and ACTRIMS in Dallas, TX. Dr. Metz, a neuropathologist at University Medical Center, Georg August University in Gottingen, Germany, noted that this hypothesis was advanced in a paper published in 2000 (Ann Neurol. 2000 Jun:47(6):707-17), in which Claudia F. Lucchinetti, MD, of the Mayo Clinic and other investigators assessed 51 biopsies and 32 autopsies that had been collected in three international center… Read More

© 2014, Delaware Media Group, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the presenters and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, or Biogen Idec.